CVSH34 Stock Overview
Provides health solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CVS Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$32.34 |
| 52 Week High | US$40.43 |
| 52 Week Low | US$27.57 |
| Beta | 0.54 |
| 11 Month Change | -8.13% |
| 3 Month Change | 0% |
| 1 Year Change | -3.06% |
| 33 Year Change | -37.99% |
| 5 Year Change | 2.83% |
| Change since IPO | -10.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSH34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0.2% | 0.3% | -0.06% |
| 1Y | -3.1% | -13.6% | -1.6% |
Return vs Industry: CVSH34 exceeded the BR Healthcare industry which returned -13.6% over the past year.
Return vs Market: CVSH34 underperformed the BR Market which returned -1.6% over the past year.
Price Volatility
| CVSH34 volatility | |
|---|---|
| CVSH34 Average Weekly Movement | 6.7% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 8.5% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: CVSH34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: CVSH34's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
CVS Health Corporation Fundamentals Summary
| CVSH34 fundamental statistics | |
|---|---|
| Market cap | R$387.95b |
| Earnings (TTM) | R$29.07b |
| Revenue (TTM) | R$2.13t |
14.1x
P/E Ratio0.2x
P/S RatioIs CVSH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSH34 income statement (TTM) | |
|---|---|
| Revenue | US$367.25b |
| Cost of Revenue | US$316.53b |
| Gross Profit | US$50.71b |
| Other Expenses | US$45.70b |
| Earnings | US$5.02b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.99 |
| Gross Margin | 13.81% |
| Net Profit Margin | 1.37% |
| Debt/Equity Ratio | 85.4% |
How did CVSH34 perform over the long term?
See historical performance and comparison